AMA 2023 Overdose Report IQVIA Data Naloxone

Added 11/8/23

AMA 2023 Overdose Report IQVIA Data Opioid Prescribing

Added 11/8/23

AMA 2023 Overdose Report State PDMP Registration & Use

Added 11/8/23

AMA 2023 Overdose Report IQVIA Data Buprenorphine

Added 11/8/23

What medical societies can do to help end the nation’s drug overdose and death epidemic

Updated January 2023

Total dispensed prescriptions to treat opioid use disorder (2012-2021)

From 2012 to 2021, medications to treat opioid use disorder (MOUD) increased 104%; from 2020 to 2021, however, it only increased 1.6%.

Total dispensed prescriptions for naloxone in retail pharmacies (2012-2021)

From 2016 to 2021, naloxone prescriptions dispensed from pharmacies increased from almost 134,000 to nearly 1.2 million prescriptions.

Opioid prescriptions by state (2012-2021)

From 2012 to 2021, every state in the nation saw a large decrease of prescription opioids dispensed from retail pharmacies.

Prescription drug monitoring program national survey (2022)

Physicians and other authorized users queried state prescription drug monitoring programs (PDMPs) more than 1.1 billion times in 2021

Issue brief: Nation’s drug-related overdose and death epidemic continues to worsen

This issue brief provides a one-page overview of the epidemic and select AMA advocacy initiatives and resources.

State Toolkit to End the Nation’s Drug Overdose Epidemic: Leading-Edge Actions and Strategies to Remove Barriers to Evidence-based Patient Care

The AMA and Manatt Health 2022 State Toolkit identifies more than 400 state laws, regulations, policy guidance and other select national actions being implemented to help end the nation's drug overdose epidemic.

2022 MHPAEA Report to Congress – AMA Summary

“This report underscores two simple facts: insurers will not change their behaviors without increased enforcement and accountability, and patients will continue to suffer until that happens,” according to the letter from AMA CEO James L. Madara, M.D.

AMA Substance Use and Pain Care Task Force

The AMA Substance Use and Pain Care Task Force urges physicians and other health care professions to continue taking action to help reverse the nation’s drug overdose epidemic—and the Task Force also calls on policymakers to take specific steps to remove barriers to evidence-based care for patients with pain and those with a substance use disorder.

Learn More

Be part of the solution.

Join the AMA today and help us lead the effort
to reverse the nation’s opioid epidemic.